Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New look at imaging for coronary disease in US

This article was originally published in Clinica

Executive Summary

The US Centers for Medicare & Medicaid Services (CMS) has decided to take a look at new forms of noninvasive imaging for the detection of coronary artery disease in what could eventually lead to expanded coverage of these promising modalities. The agency has scheduled a meeting of its private sector Medicare Coverage Advisory Commission (MCAC) on May 18 to consider the medical evidence for computed tomography angiography, electron beam tomography (otherwise known as ultrafast CT), cardiac magnetic resonance imaging and other possible technologies.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT051484

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel